Nasdaq Composite (^IXIC) closes above 25,500 points on July 25, 2026
Pending
✦ AI-generated prediction
Published on 23. July 2026
·
Predicted for 25. July 2026
·
Based on: Statistical Pattern
The Nasdaq Composite closed at 25,690.90 on July 23, 2026 (–0.57%). The prediction requires the index NOT to fall more than 0.7% by Friday's close on July 25. Mega-cap tech earnings (Apple, Microsoft, Meta, Amazon) are not due until July 29+, so pre-earnings positioning should be broadly supportive. Headwinds: FOMC uncertainty on July 29 may prompt mild caution. No Polymarket quote for the Nasdaq level is available; own estimate based on volatility profile and distance to target: ~72%.
Data basis for this prediction
- bloomingbit.io: Nasdaq Composite schließt 25.690,90 Punkte am 23.07.2026 (–0,57 %)
- Yahoo Finance / CNBC: S&P 500 bei 7.505,21 am 23.07.2026 – Marktumfeld stabil
- finance.yahoo.com: Alphabet Q2 2026 – Revenue-Beat stützt Tech-Sentiment am 22.07.2026
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
Sterling is trading at approximately $1.33–1.34 on July 23, 2026 (estimated from EUR/USD ~1.14–1.15 and EUR/GBP cross rate ~0.850–0.855). The Bank of England is expected to hold rates at 3.75% on July 30, 2026 (open prediction). The current Fed Funds rate is 3.50–3.75%, leaving the BoE rate marginally above — a slight carry advantage for GBP. Sustained USD weakness (EUR/USD >1.14) structurally supports GBP/USD. Headwind: during Middle East crises, the US dollar tends to strengthen (safe-haven effect). A close above 1.34 by end of August requires USD weakness to outweigh safe-haven demand and no UK policy shocks (BoE emergency cut, UK recession data). No Polymarket market for this specific strike.
📈 Economy
✦ AI
Pfizer reports Q2 2026 results on August 4, 2026, pre-market. Analyst consensus is approximately $0.68 adjusted Non-GAAP EPS (TipRanks, as of July 2026). Pfizer confirmed FY2026 guidance at Q1 results (April 2026) and beat Q1 estimates. Growth drivers: oncology pipeline (Eliquis, Vyndaqel, Padcev), normalized RSV vaccine demand, and royalties. Headwinds: Paxlovid revenues continue normalizing, and generic competition in older products weighs on gross margin. Historical beat rate: approximately 70% over the last 12 quarters. No Polymarket market available.
📈 Economy
✦ AI
Chevron reports Q2 2026 results on July 31, 2026, pre-market. Analyst consensus is approximately $5.79 adjusted Non-GAAP EPS (BusinessWire Advisory, dated July 2, 2026; UBS estimates $5.02–$5.70). WTI crude surged above $100/barrel on July 23, 2026, due to escalating Middle East tensions — this no longer affects Q2 (April–June) but may reflect a favorable Q2 average. Chevron has beaten estimates in approximately 70% of recent quarters. Key for a beat: upstream realization of Q2 average oil prices, refinery throughput, and downstream margins in Q2. Main risks: refinery write-downs and hedging losses could weigh on results.